I like your posts on OCC, they're informative and accurate. Except when you bring up that STI called MSB (Give it up, MSB is worthless trash).
The future is bright for OCC. That is, if they move their focus to the US. Australia is a waste land for biotechs, STEM and regenerative medicine.
OCC should leverage its proven success and expertise in obtaining US and EU regulatory approvals by listing its stock the US where its IP will be properly valued and recognized. Not a dual listing with ADRs.
Delist entirely from the ASX and relist on NASDAQ with roadshow and proper marketing of the science and tech to VC and investors able to move markets.
Many US biotechs with no regulatory approvals or distribution deals are valued 100x OCC, because the US/Global market is hungry for biotech.
OCC Trading, page-1307
-
- There are more pages in this discussion • 429 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.005(1.35%) |
Mkt cap ! $76.49M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.5¢ | $52.06K | 142.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20235 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 4244 | 1 |
View Market Depth
| Last trade - 14.42pm 20/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |